Autor: |
Venner, Christopher P., Leblanc, Richard, Sandhu, Irwindeep, White, Darrell J., Belch, Andrew R, Reece, Donna E, Chen, Christine I, Dolan, Sean, Kew, Andrea, Lalancette, Marc, Louzada, Martha L, McCurdy, Arleigh, McDonald, Gail T., Reiman, Tony, Rodriguez, Laura, Shepherd, Lois E., Gul, Engin, Chen, Bingshu E., Hay, Annette E |
Zdroj: |
Blood; November 2018, Vol. 132 Issue: Supplement 1 p1984-1984, 1p |
Abstrakt: |
Venner: Janssen: Honoraria, Research Funding; Celgene: Honoraria, Research Funding; Amgen: Honoraria; Takeda: Honoraria. Leblanc:Celgene Canada: Membership on an entity's Board of Directors or advisory committees; Janssen Inc.: Membership on an entity's Board of Directors or advisory committees; Amgen Canada: Membership on an entity's Board of Directors or advisory committees; Takeda Canada: Membership on an entity's Board of Directors or advisory committees. Sandhu:Celgene: Honoraria; Janssen: Honoraria; Amgen: Honoraria; Novartis: Honoraria; Bioverativ: Honoraria. White:Amgen, Celgene, Janssen, Takeda: Honoraria. Chen:Amgen: Honoraria. Louzada:Celgene: Honoraria; Janssen: Honoraria; amgen: Honoraria; pfizer: Honoraria. Hay:Amgen: Research Funding; Novartis: Research Funding; Janssen: Research Funding; Roche: Research Funding; Seattle Genetics: Research Funding; Kite: Research Funding. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|